Viewing Study NCT01158534


Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2026-02-13 @ 2:57 PM
Study NCT ID: NCT01158534
Status: COMPLETED
Last Update Posted: 2012-08-07
First Post: 2010-07-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery
Sponsor: Case Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Cancer View
None Stage IV Renal Cell Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent renal cell cancer View